Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Case Report of Paraneoplastic Pemphigus Associated With Retroperitoneal Inflammatory Myofibroblastic Tumor Pubmed



Balighi K1 ; Azizpour A1 ; Sadeghinia A1 ; Saeidi V1
Authors

Source: Acta Medica Iranica Published:2017


Abstract

Paraneoplastic pemphigus (PNP) is an autoimmune bullous disease associated with underlying neoplasms, both malignant and benign. The most constant clinical presentation of PNP is the presence of intractable stomatitis. Herein we present a 25-year-old male with a 3-month history of refractory stomatitis especially involving the lips and widespread vesiculobullous eruption on his trunk and extremities. The diagnosis of PNP was confirmed based on histological and serological results. Investigation for the underlying neoplasm revealed a retroperitoneal tumorous mass which was biopsied and diagnosed as the inflammatory myofibroblastic tumor (IMT). The tumor was surgically excised, and different treatment regimens were used to treat the mucocutaneous lesions. Skin lesions responded favorably to treatment, but oral stomatitis still persists which is the case in most PNP patients. This combination of PNP and IMT has rarely been reported in the literature. Treatment started with corticosteroid and rituximab then tumor excised. © 2017 Tehran University of Medical Sciences. All rights reserved.
Other Related Docs
4. A Comparative Study of Syndecan-1 Expression in Different Odontogenic Tumors, Journal of Oral Biology and Craniofacial Research (2017)
8. A Rare Erosive Orbital Mass in a Child: Case Report of Myofibroma, Journal of Current Ophthalmology (2017)
10. Inflammatory Myofibroblastic Tumor: Two Cases in Head and Neck Region, Indian Journal of Otolaryngology and Head and Neck Surgery (2022)
11. A Deep Giant Aggressive Angiomyxoma of the Labia Majora: A Case Report, International Journal of Surgery Case Reports (2022)
19. Pecoma of the Ovary: A Case Report, Journal of Obstetrics# Gynecology and Cancer Research (2022)